Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1991-4-4
pubmed:abstractText
The pharmacokinetics of oral fluoroquinolone antibiotics in normal volunteers have been studied extensively; however, limited patient data exist. Enoxacin steady-state pharmacokinetics and bioavailability were determined following repeated 400-mg intravenous (i.v.) and oral dosing by using compartmental and noncompartmental methods in 10 elderly (mean age, 73.8 years) men with complicated urinary tract infections. Average peak enoxacin concentrations following i.v. and oral dosing were 8.15 and 5.45 mg/liter, respectively. Mean values for major pharmacokinetic parameters (noncompartmental) were similar following i.v. and oral administration, respectively: area under the concentration-time curve from 0 to 12 h, 47.6 and 41.0 mg.h/liter; volume of distribution or volume of distribution/bioavailability, 1.61 and 1.99 liters/kg; total body clearance or total body clearance/bioavailability, 2.58 and 3.01 ml/min per kg; and half-life, 8.2 and 9.1 h. Parameters from analysis of enoxacin plasma concentration data by using a two-compartment pharmacokinetic model also revealed marked similarities between the two administration routes. Enoxacin was highly bioavailable (mean, 86.97%) following oral administration.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-1244564, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-2221856, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-2653697, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-2933340, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-2940518, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-2941402, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3063494, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3116917, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3162906, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3282749, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3296097, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3470166, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3471751, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-3480221, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-6389476, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-6594324, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-6707904, http://linkedlifedata.com/resource/pubmed/commentcorrection/2291662-7040951
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1966-72
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
pubmed:affiliation
Antiinfective Pharmacology Research Unit, University of Rhode Island College of Pharmacy, Providence.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't